Article
Inhibitory effect of eslicarbazepine acetate and S-licarbazepine on Na <sub>v</sub> 1.5 channels
2020-04-25
Abstract excerpt
Eslicarbazepine acetate (ESL) is a dibenzazepine anticonvulsant approved as adjunctive treatment for partial-onset epileptic seizures. Following first pass hydrolysis of ESL, S-licarbazepine (S-Lic) represents around 95 % of circulating active metabolites. S-Lic is the main enantiomer responsible for anticonvulsant activity and this is proposed to be through the blockade of voltage-gated Na + channels (VGSCs). ES...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0a3f0736-c1f4-512c-9a23-b5f3fa00fe63
- DOI
- 10.1101/2020.04.24.059188
